Literature DB >> 3170409

Alveolar liquid and protein clearance from normal dog lungs.

Y Berthiaume1, V C Broaddus, M A Gropper, T Tanita, M A Matthay.   

Abstract

To determine whether liquid and protein clearance from the air spaces and lungs of anesthetized and unanesthetized dogs is the same as in sheep, we quantified these variables at three different time periods (4, 8, and 12 h) by instilling heparinized plasma (3 ml/kg) labeled with 125I-albumin into one lower lobe. Protein clearance, measured from the residual 125I-albumin in the lung homogenate, was slow and monoexponential (approximately 1%/h), similar to our previous data for protein clearance from the lungs in sheep. Lung liquid clearance in dogs, however, was 50% less than in previous experiments in sheep. Residual lung liquid (as percent of instilled) was 88.7 +/- 7.0 at 4 h, 70.5 +/- 9.1 at 8 h, and 64.0 +/- 5.8 at 12 h. At each time period, alveolar protein concentration increased by 0.6 +/- 0.4 g/dl at 4 h, 1.3 +/- 1.2 g/dl at 8 h, and 2.1 +/- 0.8 g/dl at 12 h. This increase in alveolar protein concentration was proportional to the volume of liquid removed from the lungs. beta-Adrenergic agonist therapy with terbutaline (10(-5) M mixed with the instilled plasma) doubled the volume of liquid cleared from the lungs over 4 h, and the alveolar protein concentration increased proportionally. However, lung liquid clearance in dogs that were treated with beta-agonists was proportionally (50%) less than in sheep treated with beta-agonists. The slower liquid clearance in dogs compared with sheep cannot be explained by differences in hemodynamics, pulmonary blood flow, anesthesia, mode of ventilation, or alveolar surface area.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3170409     DOI: 10.1152/jappl.1988.65.2.585

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  30 in total

Review 1.  Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium.

Authors:  Y Berthiaume; O Lesur; A Dagenais
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

Review 2.  Resolution of pulmonary edema. New insights.

Authors:  M A Matthay
Journal:  West J Med       Date:  1991-03

Review 3.  The adult respiratory distress syndrome. New insights into diagnosis, pathophysiology, and treatment.

Authors:  M A Matthay
Journal:  West J Med       Date:  1989-02

Review 4.  Alveolar epithelial beta2-adrenergic receptors.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-20       Impact factor: 6.914

Review 5.  Acute lung injury: epidemiology, pathogenesis, and treatment.

Authors:  Elizabeth R Johnson; Michael A Matthay
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-08       Impact factor: 2.849

Review 6.  Elective cesarean section: its impact on neonatal respiratory outcome.

Authors:  Ashwin Ramachandrappa; Lucky Jain
Journal:  Clin Perinatol       Date:  2008-06       Impact factor: 3.430

7.  Mechanisms of liquid flux across pulmonary alveolar epithelial cell monolayers.

Authors:  G S Filippatos; W F Hughes; R Qiao; J I Sznajder; B D Uhal
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-03       Impact factor: 2.416

8.  Role of kinesin light chain-2 of kinesin-1 in the traffic of Na,K-ATPase-containing vesicles in alveolar epithelial cells.

Authors:  Humberto E Trejo; Emilia Lecuona; Doris Grillo; Igal Szleifer; Oksana E Nekrasova; Vladimir I Gelfand; Jacob I Sznajder
Journal:  FASEB J       Date:  2009-09-22       Impact factor: 5.191

9.  Hydrostatic mechanisms may contribute to the pathogenesis of human re-expansion pulmonary edema.

Authors:  Richard D Sue; Michael A Matthay; Lorraine B Ware
Journal:  Intensive Care Med       Date:  2004-07-17       Impact factor: 17.440

10.  Alveolar fluid clearance in healthy pigs and influence of positive end-expiratory pressure.

Authors:  Manuel García-Delgado; Angel Touma-Fernández; Virginia Chamorro-Marín; Antonio Ruiz-Aguilar; Eduardo Aguilar-Alonso; Enrique Fernández-Mondéjar
Journal:  Crit Care       Date:  2010-03-16       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.